Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Metabolic syndrome - the consequence of lifelong treatment of bipolar affective disorder.

Dadić-Hero E, Ruzić K, Grahovac T, Petranović D, Graovac M, Palijan TZ.

Psychiatr Danub. 2010 Jun;22(2):381-4.

2.

Treatment of bipolar disorders and metabolic syndrome: implications for primary care.

Bell PF, McKenna JP, Roscoe BM.

Postgrad Med. 2009 Sep;121(5):140-4. doi: 10.3810/pgm.2009.09.2060. Review.

PMID:
19820282
3.

Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.

Elmslie JL, Porter RJ, Joyce PR, Hunt PJ, Shand BI, Scott RS.

Aust N Z J Psychiatry. 2009 Jan;43(1):53-60. doi: 10.1080/00048670802534341.

PMID:
19085528
4.

Medical risk in patients with bipolar disorder and schizophrenia.

Newcomer JW.

J Clin Psychiatry. 2006;67 Suppl 9:25-30; discussion 36-42. Review.

5.

[Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].

Verdoux H, Gaudron Y, Auleley GR, Deligne J, Blum-Boisgard C, Thiébaut A, Tournier M.

Encephale. 2013 May;39 Suppl 1:S22-8. doi: 10.1016/j.encep.2012.10.009. Epub 2012 Dec 13. French.

PMID:
23246328
6.

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics.

Correll CU, Frederickson AM, Kane JM, Manu P.

Bipolar Disord. 2008 Nov;10(7):788-97. doi: 10.1111/j.1399-5618.2008.00625.x.

PMID:
19032710
7.

Prolactin-related and metabolic adverse effects of atypical antipsychotic agents.

Henderson DC, Doraiswamy PM.

J Clin Psychiatry. 2008;69 Suppl 1:32-44. Review.

8.

Bipolar disorder and metabolic syndrome: comorbidity or side effects of treatment of bipolar disorder.

Babić D, Maslov B, Martinac M, Nikolić K, Uzun S, Kozumplik O.

Psychiatr Danub. 2010 Mar;22(1):75-8. Review.

9.

Rational polypharmacy in the bipolar affective disorders.

Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.

Epilepsy Res Suppl. 1996;11:153-80. Review.

PMID:
9294735
10.

Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists.

Bauer M, Lecrubier Y, Suppes T.

Eur Psychiatry. 2008 Apr;23(3):169-77. Epub 2007 Dec 21.

PMID:
18160267
11.

Obesity and metabolic syndrome in a psychiatric rehabilitation service.

Tirupati S, Chua LE.

Aust N Z J Psychiatry. 2007 Jul;41(7):606-10.

PMID:
17558623
12.

Diagnosing and treating comorbid (complicated) bipolar disorder.

McElroy SL.

J Clin Psychiatry. 2004;65 Suppl 15:35-44. Review.

13.

Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.

Schneiderhan ME, Batscha CL, Rosen C.

Pharmacotherapy. 2009 Aug;29(8):975-87. doi: 10.1592/phco.29.8.975.

PMID:
19637951
14.

Modal subcomponents of metabolic syndrome in patients with bipolar disorder.

Cardenas J, Frye MA, Marusak SL, Levander EM, Chirichigno JW, Lewis S, Nakelsky S, Hwang S, Mintz J, Altshuler LL.

J Affect Disord. 2008 Feb;106(1-2):91-7. Epub 2007 Jul 12.

PMID:
17628693
15.

Medical monitoring in patients with bipolar disorder: a review of data.

Fagiolini A.

J Clin Psychiatry. 2008 Jun;69(6):e16.

16.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

17.

[The metabolic syndrome and antipsychotics in children and adolescents].

Dori N, Green T.

Harefuah. 2011 Oct;150(10):791-6, 814, 813. Review. Hebrew.

PMID:
22111125
18.

Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.

Sicras A, Rejas J, Navarro R, Serrat J, Blanca M.

Bipolar Disord. 2008 Jul;10(5):607-16. doi: 10.1111/j.1399-5618.2008.00599.x.

PMID:
18657245
20.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448

Supplemental Content

Support Center